A Randomized Controlled Trial of Dabigatran versus Warfarin for Periablation Anticoagulation in Patients Undergoing Ablation of Atrial Fibrillation.

MLA

Nin, Takamitsu, et al. “A Randomized Controlled Trial of Dabigatran versus Warfarin for Periablation Anticoagulation in Patients Undergoing Ablation of Atrial Fibrillation.” Pacing & Clinical Electrophysiology, vol. 36, no. 2, Feb. 2013, pp. 172–79. EBSCOhost, https://doi.org/10.1111/pace.12036.

APA

Nin, T., Sairaku, A., Yoshida, Y., Kamiya, H., Tatematsu, Y., Nanasato, M., Inden, Y., Hirayama, H., & Murohara, T. (2013). A Randomized Controlled Trial of Dabigatran versus Warfarin for Periablation Anticoagulation in Patients Undergoing Ablation of Atrial Fibrillation. Pacing & Clinical Electrophysiology, 36(2), 172–179. https://doi.org/10.1111/pace.12036

Chicago

Nin, Takamitsu, Akinori Sairaku, Yukihiko Yoshida, Hiroki Kamiya, Yasushi Tatematsu, Mamoru Nanasato, Yasuya Inden, Haruo Hirayama, and Toyoaki Murohara. 2013. “A Randomized Controlled Trial of Dabigatran versus Warfarin for Periablation Anticoagulation in Patients Undergoing Ablation of Atrial Fibrillation.” Pacing & Clinical Electrophysiology 36 (2): 172–79. doi:10.1111/pace.12036.